Portomesenteric and Caval A Phase 1 Trial of the Oncolytic Virus SVV-001 with Nivolumab and Ipilimumab in Patients with High Grade Neuroendocrine Neoplasms.Venous Occlusion (NANETS 2026) - Oct 7, 2026 - Pres time: Nov 6, 2026; 09:05 AM - 10:20 AM; No abstract available
Clinical • Oncolytic virus • P1 data • Endocrine Cancer • Neuroendocrine Neoplasm • Oncology • Solid Tumor
|